Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company has market cap of $18.90 million. The Company’s drug development programs include Joint Pharma that develops THX-TS01 for the treatment of Tourette … Read More
The post Therapix Biosciences LTD. – American Depositary SH (NASDAQ:TRPX) Sellers Increased By … appeared first on Dagga Magazine.